Status:

UNKNOWN

Drug-eluting Beads Bronchial Arterial Chemoembolization in Stage II-III Non-small-cell Lung Cancer Patients Failed, Refused or Ineligible to Receive Standard Treatments

Lead Sponsor:

Tianjin Medical University Cancer Institute and Hospital

Conditions:

Carcinoma, Non-Small-Cell Lung

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a multicenter, prospective, single-arm clinical study to determine the efficacy and safety of Drug-eluting beads bronchial arterial chemoembolization(DEB-BACE) in stage II-III NSCLC patients w...

Eligibility Criteria

Inclusion

  • Patients ≥ 18 years old, of any sex;
  • Patients who have histopathological proof of NSCLC according to the standard of diagnosis and treatment of primary lung cancer(V2018);
  • Confirmed TNM stage is II-III of NSCLC;
  • Patients who were failed, refused or assessed ineligible by MDT to receive conventional Second-Line treatments (surgery, chemoradiotherapy, targeted and immunotherapy);
  • Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) score of 0-2;
  • Life expectancy of \> 3 months;
  • Patients volunteered to participate in this study and signed informed consent, with good compliance;

Exclusion

  • Patients received interventional therapy (I seeds implantation, Ablation, BACE) before;
  • A history combined with other malignant tumors and not cured;
  • WBC\<3×109/L、LYM\<1.5×109/L、NLR≥3、PLT\<50×109/L、HGB\<90 g/L;
  • Insufficient of liver and renal function (Cr\>176.8 µmol/L; AST and/or ALT\>2 folds of normal value);
  • Combined with uncorrectable coagulation dysfunction or active massive hemoptysis;
  • Combined with active affection and need antibiotic treatment;
  • Uncontrollable hypertension, diabetes, cardiovascular disease with obvious symptoms;
  • Known to be hypersensitive to contrast agent;
  • Pregnant or breastfeeding women;

Key Trial Info

Start Date :

May 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04825925

Start Date

May 1 2021

End Date

October 1 2024

Last Update

April 12 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.